Kaleidoscope Innovation
Colleen Murphy currently serves as the Director of Regulatory Affairs at Kaleidoscope Innovation and Product Design, a position held since June 2022. Previous experience includes roles as a Consultant in Regulatory Affairs at Regulatory Mark and as the Director of Scientific Affairs at Aniara Diagnostica, where responsibilities included managing multiple departments and preparing regulatory submissions for FDA and Health Canada. Additional expertise includes consulting on clinical data monitoring at Clarigent Health, assessing regulatory impacts at Leica Biosystems, and overseeing complex human research protocols at Cincinnati Children's Hospital Medical Center. Colleen's extensive background in regulatory and clinical research is supported by a Bachelor of Science in Biology from the University of Cincinnati, a Master of Arts in Teaching from Northern Kentucky University, and current enrollment in a Clinical and Health Informatics program at the University of Wisconsin-Madison.
This person is not in any teams
Kaleidoscope Innovation
Kaleidoscope Innovation is a provider of product design and development services.It is a full-service insight, design, and development firm that innovates across medical, consumer, and industrial markets. Kaleidoscope offers both consultancy-style and onsite services, across a full breadth of disciplines to meet their client's needs whereneeded, including insights and human factors, medical affairs, industrial design, and user experience, engineering, visualization, and software development. The company leverages a deep understanding of clinical environments, strong product development capabilities across domains, and a consultancy approach addressing human factors, product design, UI/UX design, research and insight, development and visualization.Matt Kornau established the company in Cincinnati, Ohio in 1989.